USA - engelsk - NLM (National Library of Medicine)

international medication systems, limited - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 1 mg in 0.5 ml - phytonadione injectable emulsion, usp is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity: • anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; • hypoprothrombinemia due to antibacterial therapy; • hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac     disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; • other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. phytonadione injectable emulsion, usp is indicated for prophylaxis and treatment of vitamin k-deficiency bleeding in neonates. hypersensitivity to phytonadione or any other component of this medication [see warnings a

USA - engelsk - NLM (National Library of Medicine)

teligent pharma, inc. - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 2 mg in 1 ml - phytonadione is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity: - anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; - hypoprothrombinemia due to antibacterial therapy; - hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; - other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. phytonadione is indicated for prophylaxis and treatment of vitamin k-deficiency bleeding in neonates. hypersensitivity to phytonadione or any other component of this medication. [see warnings and precautions (5.1)]. risk summary   phytonadione c

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

phytopharma s.a. - hippocastani extrait ethanolicum sec - phytopharma dragées pour les veines/venen dragées - hippocastani extrait ethanolicum sec 200 mg corresp. aescinum 40 mg, der: 5-6.5:1, excipiens pro compresso de la brume. - en cas de troubles veineux - phytoarzneimittel

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

phytopharma s.a. - betulae folii extrait aquosum raisins secs ours folii extrait aquosum sec, equiseti extrait aquosum sec, ononidis l'extrait de racine de ethanolicum sec - phytopharma bulles dragées - betulae folii extrait aquosum sec 40 mg corresp. flavonoidea 0,8 mg, der: 4.0-8.0:1, le raisin d'ours folii extrait aquosum sec 80 mg corresp. arbutinum 8 mg, der: 2.8-4.2:1, equiseti extrait aquosum sec 40 mg, der: 4-7:1, ononidis l'extrait de racine de ethanolicum sec 40 mg, der: 4-9:1, auszugsmittel ethanolum 30 % v/v, sont, excipiens pro compresso de la brume. - lors de blasenbeschwerden - phytoarzneimittel

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

phytopharma s.a. - harpagophyti radicis pulvis - phytopharma harpago - harpagophyti poudre de racine de 182.36 mg, excipiens pro compresso. - traitement d’appoint des douleurs légères dues aux signes d’usure de l’appareil locomoteur - phytoarzneimittel

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

phytopharma s.a. - hippocastani extrakt ethanolicum trocken - phytopharma dragées, um die adern/venen geht dragees - hippocastani extrakt ethanolicum trocken 200 mg endwerte. aescinum 40 mg, der: 5-6.5:1, excipiens pro compresso dunst. - bei venenbeschwerden - phytoarzneimittel

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

phytopharma s.a. - betulae folii-extrakt aquosum trockene trauben tragen folii-extrakt aquosum trocken, equiseti extrakt aquosum trocken, ononidis-wurzel-extrakt ethanolicum trocken - phytopharma blasen dragées - betulae folii-extrakt aquosum trocken 40 mg endwerte. flavonoidea 0,8 mg, der: 4.0-8.0:1, trauben tragen folii-extrakt aquosum trocken 80 mg endwerte. arbutinum 8 mg, der: 2.8-4.2:1, equiseti extrakt aquosum trocken 40 mg, der: 4-7:1, ononidis-wurzel-extrakt ethanolicum trocken 40 mg, der: 4 bis 9:1, auszugsmittel ethanolum 30 % v/v, excipiens pro compresso dunst. - bei blasenbeschwerden - phytoarzneimittel

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

phytopharma s.a. - harpagophyti radicis pulvis - phytopharma harpago - harpagophyti-wurzel-pulver 182.36 mg, excipiens pro compresso. - unterstützende behandlung leichte schmerzen durch verschleißerscheinungen des bewegungsapparates - phytoarzneimittel

USA - engelsk - NLM (National Library of Medicine)

general injectables & vaccines, inc - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 1 mg in 0.5 ml - 1.1 treatment of hypoprothrombinemia due to vitamin k deficiency or interference phytonadione injectable emulsion, usp is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity; - anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; - hypoprothrombinemia due to antibacterial therapy; - hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; - other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. 1.2 prophylaxis and treatment of vitamin k-deficiency bleeding in neonates phytonadione injectable emulsion, usp is indicated for prophylaxi

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

staufen-pharma gmbh & co.kg (3090647) - phytolacca americana (pot.-angaben) - flüssige verdünnung zur injektion - phytolacca americana (pot.-angaben) (01983) 1 milliliter